HilleVax, Inc. financial data

Symbol
HLVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Ave, Suite 500, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 864 % -36.4%
Debt-to-equity 28.3 % +6.54%
Return On Equity -75.3 % -56.3%
Return On Assets -58.7 % -54.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.1M shares +0.89%
Common Stock, Shares, Outstanding 49.7M shares +4.31%
Entity Public Float 345M USD +33.6%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49.2M shares +21.1%
Weighted Average Number of Shares Outstanding, Diluted 49.2M shares +21.1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 28.8M USD +7.97%
Operating Income (Loss) -155M USD -16.5%
Nonoperating Income (Expense) 8.02M USD -17.9%
Net Income (Loss) Attributable to Parent -147M USD -19.2%
Earnings Per Share, Basic -3 USD/shares +1.32%
Earnings Per Share, Diluted -3 USD/shares +1.32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 154M USD -28.7%
Marketable Securities, Current 17M USD -80.5%
Assets, Current 178M USD -42.6%
Property, Plant and Equipment, Net 5.22M USD -62.7%
Operating Lease, Right-of-Use Asset 7.47M USD -58.7%
Other Assets, Noncurrent 23K USD -8%
Assets 193M USD -44.1%
Accounts Payable, Current 3.24M USD -56.6%
Employee-related Liabilities, Current 207K USD -96%
Accrued Liabilities, Current 9.65M USD -48%
Liabilities, Current 16.5M USD -43.8%
Operating Lease, Liability, Noncurrent 20.9M USD -8.27%
Other Liabilities, Noncurrent 806K USD -48.6%
Liabilities 38.2M USD -51.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.14M USD -25.7%
Retained Earnings (Accumulated Deficit) -536M USD -37.9%
Stockholders' Equity Attributable to Parent 154M USD -41.8%
Liabilities and Equity 193M USD -44.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33M USD -107%
Net Cash Provided by (Used in) Financing Activities 15.1M USD +18728%
Net Cash Provided by (Used in) Investing Activities -57.7M USD -1832%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.9M shares +2.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -75.6M USD -301%
Interest Paid, Excluding Capitalized Interest, Operating Activities 382K USD +99%
Deferred Tax Assets, Valuation Allowance 81.3M USD +49.3%
Deferred Tax Assets, Gross 82.9M USD +41.9%
Operating Lease, Liability 24.5M USD -5.53%
Depreciation 1.88M USD +113%
Payments to Acquire Property, Plant, and Equipment 153K USD -94.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -148M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid 32.4M USD -9.99%
Property, Plant and Equipment, Gross 7.98M USD -46.4%
Operating Lease, Liability, Current 3.57M USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.78M USD +2.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.69M USD +2.79%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.9M USD -18.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.86M USD +1.93%
Deferred Tax Assets, Operating Loss Carryforwards 24.7M USD +139%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 976K USD +1.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.97M USD +2.95%
Operating Lease, Payments 896K USD +2.87%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.57M USD -60.2%
Share-based Payment Arrangement, Expense 20.8M USD +52.9%
Interest Expense 2.91M USD +106%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%